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respectively. Steady atate plaama DMP 728 levels exceeded the ex-vivo IC
50 for ADP and collagen induced platelet aggregation (280% inhibition); and
the IC 50 for EC adhesion and SMC migration assays. Regression models
comparing NI vs. INJ score regression lines showed significant reduction in
slope (p = 0.0001) and intercept (p = 0.0001) by DMP 728. Conckrsions:
Combined av~s and ~llb~s blockade represents an effective antirestenosis
strategy that petantly limits neointimal hypefplasia and lumen stenosis fol-
lowing deep aiierfal injury in a Iarga animal model of restenosis. The high
affinity of DMP 728 for both W% and C41b63confirma the importance of these
integrina in cellular events underlying restanosis.
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EJ7015 DecreeeedNeointimelProliferationbyinhibitionof
vonWillebrendFectorFunction
A.D. Waissbluth, G. Ghigliotti 1, D. Schwartz, D.R. Abendschein,
P.R. Eisenberg. Washington University St. Louis, MO, USA, 1University of
Geneva, Geneva, Italy
Deapite recent clinical evidence that inhibition of the platelet llb/llla receptor
may inhibit restenoeis, there are little data on the affects of inhibiting platelet
function on neointimal hyperplasia. Tha objective of this study was to char-
acterize the effects on neointimal hyperplasia of inhibition of von Willebrand
factor platelet interactions by administering aurintricerboxylic acid (ATA) in a
well defined prepa@ion of aortic injuty in the rabbit. The rabbit aortae were
deeply injured by hyperinflating a 4F balloon catheter with 0.5 ml of saline
and pasaing the catheter 3 times from proximal to distal abdominal aorta
40 minutes after a 4 mgkg intravenous bokrs of ATA, followed by the same
dose every 2 hours for 24 hours. ATA inhibited ristocetin-induced platelet
aggregation and prolonged bleeding times, an effect which leeted up to six
hours after the lest dose. Aortas were harvested 2 weeks after injury and
VVG stained croas-sections were studied to confirm the extent of injury and
to calculate intimal to medial (I:M) area ratios. The mean I:M area ratio wee
decreased by 28% in rabbits after injury when ATAwas administered (0.23
+ 0.03 [SE], n = 6) compared with rabbits not given ATA but subjected to
the same injury (0.32 + 0.02, n = 16, p = 0.032). Thus, inhibition of von
Willebrend factor function for only 24 hours after arterial injury attenuated
neointimal hyperplasia at 2 weeks.
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701-6 LocallyDeliveredVescularEndothalialGrowth
Factor(VEGF)DoeeNotInhibitNeointimal
ProliferationinThePorcineReetenoeiaModal
G.Belli, D.S. Eccleaton, M.C. Horrigan, J.G. Furst, A.M. Lincoff, E.J. Topol.
The Cleveland Clinic Foundation, Cleveland, Ohio, USA
Background: Vascular endothelial growth factor (VEGF) accelerates en-
dothelial growth and by modulating smooth muscle cell proliferation inhibits
reatenoais in the rat carotid injury model. We hypothesized a similar effect of
100allydelivered VEGF in the porcine coronaty injury model. Methods: After
oversized balloon injury, 17 juvenile pigs were blindly randomized to infusion
of VEGF, 1000 wg in 5 min. or placebo with a Diepatch local drug-delivery
catheter. Animals were sacrificed at 28 days with histologic and morpho-
metrfc analysis of the pressure perfusion fixed injured coronay segmants.
Reau/fe:Adaquate injury with internal elastic Iamina rupture was obtained in
23 atierial segments.
PLACEBO(n= 11) VEGF(n = 12) P 95°ACl
NA(mmz) 0.4+0.3 0.5+0.2 0.6 -0.5 to 0.3
‘A NA 46* 17 45 *2O 0.9 -15 to 1s
LA (mm2) 0.2 * 0.2 0.2 +0.2 0.s -0.2 to0.2
Injury 2.6+ 0.9 2.6+ 1.0 0.9 –0.9 to 0.9
NA = NsointimalAreS.%NA=neointimtiexternalelaaticlaminareax 100. M= Iuminal
area. Injury=Injuryscore
Cone/uaiorr: Locally delivered VEGF, at the dose and delivery method
uaed, does not inhibit neointimal proliferation in tha porcine corona~ artery
injury model. This finding suggests the possibility of important inter-species
difference in restenosis.
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~1 in-ho.Pi~lmen~~ementof a~utemYo~ard,a,
infarction:resultsof USIK,e nationwideFrench
Suwey
N.Danchin, L. Vaur, N. Genea, M. Renault, S. Etienne, J. Ferribres,
J.-P. Cambou. CHIJNancy-Brafwis 54500, France
Recommendations for the traatmant of Ml have undergone major changes
related to the results of recent randomized therapeutic trials. The impact of
these academic recommendations on the actual management of pte with
AMI is less well known. The USIK survey is a nationwide survey of all pta
admitted for AMI to any French institution in November 1995. Its aim was
to assess both actual therapeutic management of the pte and in-hospital
complications over the first 5 days of the Ml. Information was collected for
2563 consecutive pts admitted within 48 hrs of initial chest pain in the 373
participating institutions and who met the usual criteria for Ml. Mean age
was 67 + 14 yre; 71% were men. Risk factors: hyperfenaion: 46%, diabetes
mellitus: 17%, hyperlipidemia: 36%, smoking: 31% and previous Ml: 18%.
Management: 63% were admitted within 6 hrs of chest pain onset; 80% had
LVfuncfion aseesaadbyeohooardiography orangiography; thrombolysis was
uaed in 32% and PTCA in ‘19%. Haparin was used in 96%, aspirin in 91%,
nitratea in 68%, beteblockera in 85%, ACE inhibitors in 46%, diuretica in 35%,
anti-arrhythmia agOfItS h 200A,calcium antaagonista in 17% and digitalis in
5%. Five-day rnortaMywas 7.7%. Numerous factors were related tooutcoma
by univariate analysis. By x-variate logistic regression analyais, only LVEF
and age were independent predictors: mortality increased from 2.1% for age
<65 yrs to 11.47. beyond, and fmm 2.6Y0 for LVEF > 35% to 18Y0for LVEF
< 36%. Theae results show that current recommendations have actually
altered the management of pts with acutb Ml, reaulting in improved early
aurvival. LV function still represents the main determinant of early outcome.
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~~ Lefiventr,.u,arThrOmbOsisinpatientsw~h~~ute
MyocardialInfarctionAdmittedto GISSI-3Trial
F. Chiarella, A. Maggioni 1, S. Domenicucci, P. Bellotti, E. Santoro 1,
C. Vecchio for the GISSI-3 Investigators. Cardiology Division Ga//iera
Hoapital, Genoa, Italfi 1GISSI-3 Centec ANMCO/M. Negri Institute, Italy
To avaluate the rate of occurrence of left ventricular thrombosis (LVT), we
analyzed the predischarge (average 10 day) 2D-echocardiograms available
for 8326 of ILW95 pts with acute myocardial infarction (AMI) admittad to
GISSI-3 trial by 200 Coronay Care Units. Overall, LVT was obsewed in 427
(5.1%): 292/2544 (11.5%) with anterior AMI and 135/5782 (2.3%) with other
site AMI (2p < 0.00W). Multiple logistic regression analysis was performed in
pts with anterior AMI to identify independent risk factors of LVT occurrence.
Fatior OR 95%cl
Killip>1
P
1.75 1.2S-2.39 0.0005
Acuteiv. Atenoiol 1.32 1,02-1.75 0,0365
Historyof diabetes 1.26 0.90-1.76 NS
Lisinooril 1.05 0.S2-1.34 NS
PrevioueAMI 1.02 0.63-1.64 NS
Aspirin 1.02 0.72-1.45 NS
Thrombolysis 1,20 0.73-1.38 NS
Age >70 0.97 0.70-1.35 NS
Nitrates 0,96 0.75-1.23 NS
Historyof Hy@rtension 0.86 0.67-1.14 NS
In mnclusion, in a large population of pte with anterior AMl randomized to
GISSI-3 trial, the predischarge echo showad that: 1) LVT occurred in 11.5%;
2) cardiac impairment at entry (Killip claas >1) and iv. acute Atenolol admin-
istration ware factors independently associated with a higher risk of LVT.
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1702-31~:~$[::ofcorOnaWcmPrOmisLeadin~tOR
T.R. Bowers, D.G. Aliabadi, F.V.Tilli, M.C. Pica, W.W. O’Neill,
J.A. Goldatein. William Beaumont Hoapital, F?oya/Oa/r,Ml, USA
RV infarction (RVI) has been attributed to proximal RCA occlusion. Yet, this
correlate is baaed on small studiea and does not thoroughly explain the
angiogrephic etiology of RVI. The patterna of corona~ compromise leading
